Emily Bodnar
Stock Analyst at H.C. Wainwright
Total Price Targets
26
Stocks Covered
12
Sectors
Healthcare
Most Recent
Mar 9, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Emily Bodnar
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | $38.00 | $14.47 | +162.5% | 4 | Mar 9, 2026 |
| ANAB | AnaptysBio, Inc. | $66.00 | $66.67 | -1.0% | 3 | Mar 4, 2026 |
| SANA | Sana Biotechnology, Inc. | $7.00 | $3.30 | +112.1% | 3 | Mar 4, 2026 |
| ACLX | Arcellx, Inc. | $115.00 | $115.07 | -0.1% | 2 | Feb 23, 2026 |
| AGIO | Agios Pharmaceuticals, Inc. | $56.00 | $28.15 | +98.9% | 1 | Oct 20, 2025 |
| TGTX | TG Therapeutics, Inc. | $60.00 | $33.92 | +76.9% | 1 | Oct 6, 2025 |
| INKT | MiNK Therapeutics, Inc. | $35.00 | $11.90 | +194.0% | 1 | Jul 15, 2025 |
| GERN | Geron Corporation | $8.00 | $1.58 | +404.7% | 1 | Nov 5, 2024 |
| RCUS | Arcus Biosciences, Inc. | $20.00 | $25.66 | -22.1% | 1 | Oct 21, 2024 |
| NVCR | NovoCure Limited | $30.00 | $16.49 | +81.9% | 5 | Oct 16, 2024 |
| CNTX | Context Therapeutics Inc. | $6.00 | $2.31 | +160.3% | 2 | Aug 8, 2024 |
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $22.00 | $2.05 | +973.2% | 2 | May 14, 2024 |
Recent Activity
- Mar 9, 2026— Set$38.00price target onOLMA(Olema Pharmaceuticals, Inc.)
- Mar 4, 2026— Set$66.00price target onANAB(AnaptysBio, Inc.)
- Mar 4, 2026— Set$7.00price target onSANA(Sana Biotechnology, Inc.)
- Feb 23, 2026— Set$115.00price target onACLX(Arcellx, Inc.)
- Dec 11, 2025— Set$45.00price target onOLMA(Olema Pharmaceuticals, Inc.)
- Oct 20, 2025— Set$56.00price target onAGIO(Agios Pharmaceuticals, Inc.)
- Oct 20, 2025— Set$28.00price target onOLMA(Olema Pharmaceuticals, Inc.)
- Oct 6, 2025— Set$60.00price target onTGTX(TG Therapeutics, Inc.)
- Jul 15, 2025— Set$35.00price target onINKT(MiNK Therapeutics, Inc.)
- Dec 11, 2024— Set$19.00price target onANAB(AnaptysBio, Inc.)
- Nov 6, 2024— Set$95.00price target onACLX(Arcellx, Inc.)
- Nov 6, 2024— Set$52.00price target onANAB(AnaptysBio, Inc.)
- Nov 5, 2024— Set$8.00price target onGERN(Geron Corporation)
- Nov 5, 2024— Set$8.00price target onSANA(Sana Biotechnology, Inc.)
- Oct 21, 2024— Set$20.00price target onRCUS(Arcus Biosciences, Inc.)
- Oct 16, 2024— Set$30.00price target onNVCR(NovoCure Limited)
- Aug 8, 2024— Set$6.00price target onCNTX(Context Therapeutics Inc.)
- Jul 26, 2024— Set$24.00price target onNVCR(NovoCure Limited)
- May 16, 2024— Set$30.00price target onOLMA(Olema Pharmaceuticals, Inc.)
- May 14, 2024— Set$22.00price target onACRV(Acrivon Therapeutics, Inc. Common Stock)
Frequently Asked Questions
Who is Emily Bodnar?
Emily Bodnar is a stock analyst at H.C. Wainwright covering 12 stocks primarily in Healthcare. They have issued 26 price targets since May 16, 2022.
What stocks does Emily Bodnar cover?
Emily Bodnar currently covers 12 stocks, including NVCR, OLMA, ANAB, SANA, ACLX.
What is Emily Bodnar's latest price target?
Emily Bodnar's most recent price target was $38.00 on OLMA (Olema Pharmaceuticals, Inc.), set on Mar 9, 2026.
What is Emily Bodnar's highest price target?
Emily Bodnar's highest issued price target is $140.00 on NVCR, set on Jan 5, 2023.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.